Clinical Trial Update: Effect on Cognitive Function of a Treatment With Aripiprazole [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the effect of aripiprazole on cognitive function in schizophrenia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED